[
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "EXPRESS WARRANTIES MONDO USE source name_ and _assay name TIP HTML dissociation method HEREIN MS:1001251 PO BTO HF MUST UBERON BUT OF DTT IMPLIED MERCHANTABILITY III CLO TMT CL PEPTIDESEQ BRENDA RAW OPTIONAL RECOMMEND label COLUMN EFO OR instrument MAGE IS LIMITED CID depletion SH sample exclamation VK URI ZFA NOT IDF SHALL URL MC ID ROW REQUIRED XML technical replicate LI LC FDR STANDARDS README THAT PMID ancestry category EW individual CN TA NOTE disease stage XL SRM file your INCLUDING WILL ALL ISA collision energy SN PATCH MHC DJ CS JA MT CF cell type RIGHTS DIA PARTICULAR PROTEOMICS organism organism part CPTAC spiked compound sex FITNESS INFORMATION fraction identifier CV PRIDE MOD EBI SILAC PP REQUIRES MINOR characteristics VCF ... PMCID SDRF SP INITIATIVE DISCLAIMS RECOMMENDED pooled sample MIAME HCD developmental stage FOR ANY data file RFC PRM PATO MAY NCBI DDA PURPOSE PRIDE:0000659 SWATH II NCE WARRANTY PTM proteomics data acquisition method cleavage agent details MS IMPORTANT HANCESTRO biological replicate COULD BE replicate alkylation reagent reduction reagent NT HUPO source name CT AC SHOULD ENVO IAA INFRINGE PSI TAB EM PS BMC age mass DOID MAJOR CELL THE fractionation method QY disease biosample accession number AS TO"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "EXPRESS WARRANTIES MONDO USE HTML dissociation method HEREIN MS:1001251 PO BTO HF MUST UBERON BUT OF DTT IMPLIED MERCHANTABILITY III CLO TMT CL PEPTIDESEQ BRENDA RAW OPTIONAL RECOMMEND label COLUMN EFO OR instrument MAGE IS LIMITED CID depletion SH VK URI ZFA NOT IDF SHALL URL MC ROW REQUIRED technical replicate LI LC FDR STANDARDS README THAT PMID ancestry category EW individual CN TA disease stage XL SRM INCLUDING WILL ALL ISA collision energy SN PATCH MHC DJ CS JA MT CF cell type RIGHTS DIA PARTICULAR PROTEOMICS organism organism part CPTAC spiked compound sex FITNESS INFORMATION fraction identifier CV PRIDE MOD EBI SILAC PP REQUIRES MINOR VCF ... PMCID SDRF SP INITIATIVE DISCLAIMS RECOMMENDED pooled sample MIAME HCD FOR ANY data file RFC PRM PATO MAY NCBI DDA PURPOSE PRIDE:0000659 SWATH II NCE WARRANTY PTM proteomics data acquisition method cleavage agent details MS HANCESTRO biological replicate COULD BE alkylation reagent reduction reagent NT HUPO CT AC SHOULD ENVO IAA INFRINGE PSI TAB EM PS BMC age mass DOID MAJOR CELL THE fractionation method QY disease biosample accession number AS TO"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "MONDO TIP UBERON:0001969 CL:0000182 CL:0000084 NK PATO:0000383 PO UBERON MUST CL PATO:0000384 PATO:0000461 EFO UBERON:0001359 synthetic peptide NSG CL:0000540 CL:0000898 depletion CL:0000913 exclamation UBERON:0000948 UBERON:0002048 disease model UBERON:0000310 URL ID UBERON:0002113 COVID ancestry category DSS individual xenograft NOTE UBERON:0001977 UBERON:0002107 ALL CL:0000235 MONDO:0005148 MONDO:0005575 MONDO:0005180 UBERON:0001155 cell type PATO:0001340 CL:0000624 organism UBERON:0000955 organism part sex MONDO:0004975 CL:0000232 CL:0000625 CL:0000813 CL:0000788 CL:0000233 enrichment process CL:0000236 MONDO:0004946 SDRF CL:0000623 lib CSF PDX CL:0000787 developmental stage NCBI PATO MONDO:0005138 MONDO:0008383 MAY CML MONDO:0005301 PTM IMPORTANT UBERON:0001088 HANCESTRO biological replicate compound CL:0000815 UBERON:0002097 CL:0000451 source name SHOULD CL:0000576 APP age DOID UBERON:0000178 CL:0000066 MONDO:0005105 MONDO:0100096 MONDO:0004989 disease CL:0000057"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "MONDO UBERON:0001969 CL:0000182 CL:0000084 NK PATO:0000383 PO UBERON MUST CL PATO:0000384 PATO:0000461 EFO UBERON:0001359 synthetic peptide NSG CL:0000540 CL:0000898 depletion CL:0000913 UBERON:0000948 UBERON:0002048 disease model UBERON:0000310 URL ID UBERON:0002113 COVID ancestry category DSS individual xenograft UBERON:0001977 UBERON:0002107 ALL CL:0000235 MONDO:0005148 MONDO:0005575 MONDO:0005180 UBERON:0001155 cell type PATO:0001340 CL:0000624 organism UBERON:0000955 organism part sex MONDO:0004975 CL:0000232 CL:0000625 CL:0000813 CL:0000788 CL:0000233 enrichment process CL:0000236 MONDO:0004946 SDRF CL:0000623 CSF PDX CL:0000787 developmental stage NCBI PATO MONDO:0005138 MONDO:0008383 MAY CML MONDO:0005301 PTM UBERON:0001088 HANCESTRO biological replicate compound CL:0000815 UBERON:0002097 CL:0000451 source name SHOULD CL:0000576 APP age DOID UBERON:0000178 CL:0000066 MONDO:0005105 MONDO:0100096 MONDO:0004989 disease CL:0000057"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C28077 height gestational age UO MONDO NCIT:C65106 medication history NCIT:C15329 MONDO:0004979 NCIT:C53554 diet NCIT:C65108 treatment status III treatment BMI EFO NCIT:C28079 NCIT:C14174 body mass index NCIT NCIT:C65107 NCIT:C28076 smoking status secondary condition weight NCIT:C71732 NCIT:C14167 NCIT:C16358 exclamation alcohol consumption CHEBI:28748 ID Ann Arbor stage MONDO:0004995 NCIT:C53555 ancestry category NCI individual ethnicity HANCESTRO:0010 NCIT:C53553 NOTE disease stage NCIT:C14168 ER PD MONDO:0005148 NCIT:C15262 NCIT:C18213 GDPR NCIT:C81328 MONDO:0011122 AJCC PREFERRED organism organism part sex CHEBI:27899 IV HANCESTRO:0009 time post treatment treatment response HANCESTRO:0005 SDRF NCIT:C27966 NCIT:C81327 NCIT:C68804 NCIT:C28054 TNM NCIT:C28078 NCIT:C62723 dose pregnancy status sampling time point PR CHEBI:41774 NCIT:C4870 II menopausal status NCIT:C15445 NCIT:C27970 HANCESTRO:0006 tumor grade IMPORTANT Dukes stage MONDO:0002050 prior treatment HANCESTRO pre-existing condition NCIT:C53556 TNM staging compound NCIT:C15632 MONDO:0005300 HIPAA NCIT:C14169 MONDO:0005044 NCIT:C27971 NCIT:C18206 age breast cancer subtype CHEBI:6801 NCIT:C18058 disease NCIT:C15313 ACE"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C28077 height gestational age UO MONDO NCIT:C65106 medication history NCIT:C15329 MONDO:0004979 NCIT:C53554 diet NCIT:C65108 treatment status III treatment BMI EFO NCIT:C28079 NCIT:C14174 body mass index NCIT NCIT:C65107 NCIT:C28076 smoking status secondary condition weight NCIT:C71732 NCIT:C14167 NCIT:C16358 alcohol consumption CHEBI:28748 ID Ann Arbor stage MONDO:0004995 NCIT:C53555 ancestry category NCI individual ethnicity HANCESTRO:0010 NCIT:C53553 disease stage NCIT:C14168 ER PD MONDO:0005148 NCIT:C15262 NCIT:C18213 GDPR NCIT:C81328 MONDO:0011122 AJCC PREFERRED organism organism part sex CHEBI:27899 IV HANCESTRO:0009 time post treatment treatment response HANCESTRO:0005 SDRF NCIT:C27966 NCIT:C81327 NCIT:C68804 NCIT:C28054 TNM NCIT:C28078 NCIT:C62723 dose pregnancy status sampling time point PR CHEBI:41774 NCIT:C4870 II menopausal status NCIT:C15445 NCIT:C27970 HANCESTRO:0006 tumor grade Dukes stage MONDO:0002050 prior treatment HANCESTRO pre-existing condition NCIT:C53556 TNM staging compound NCIT:C15632 MONDO:0005300 HIPAA NCIT:C14169 MONDO:0005044 NCIT:C27971 NCIT:C18206 age breast cancer subtype CHEBI:6801 NCIT:C18058 disease NCIT:C15313 ACE"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "IMPORTANT FTP MSD UNIMOD:1 MS:1001917 UNIMOD:737 exclamation URI file uri fraction identifier KR PRIDE TIP SILAC MOD PP TOF MS:1001309 NT MS1 scan range URL ID SHOULD REQUIRED AC UNIMOD:35 MS:1001251 MS2 analyzer type HF MUST UNIMOD PSI MS:1001303 technical replicate SDRF modification parameters MRM RECOMMENDED fraction TA TMT NOTE scan window lower limit RAW MS:1001313 proteomexchange accession number XL SRM data file PRM DDA SCIEX label scan window upper limit ELISA MGF fragment mass tolerance LTQ instrument MM MS:1001306 PRIDE:0000663 UNIMOD:21 CS MT ST UNIMOD:4 CF precursor mass tolerance DIA RPPA proteomics data acquisition method cleavage agent details TS MS sample"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "FTP MSD UNIMOD:1 MS:1001917 UNIMOD:737 URI file uri fraction identifier KR PRIDE MOD SILAC TOF PP MS1 scan range MS:1001309 NT URL ID SHOULD REQUIRED AC UNIMOD:35 MS:1001251 MS2 analyzer type HF MUST UNIMOD PSI MS:1001303 technical replicate SDRF modification parameters MRM RECOMMENDED TA TMT scan window lower limit RAW MS:1001313 proteomexchange accession number XL SRM data file PRM DDA SCIEX label scan window upper limit ELISA MGF fragment mass tolerance LTQ instrument MM MS:1001306 PRIDE:0000663 UNIMOD:21 CS MT ST UNIMOD:4 CF precursor mass tolerance DIA RPPA proteomics data acquisition method cleavage agent details TS MS"
  }
]